See analyst estimates and all valuation multiples for Chemicals
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $242B | 7.3x | 18.5x | |
| $101B | 4.4x | 22.1x | |
| $84.9B | 5.3x | 22.9x | |
| $79.8B | 6.7x | 15.9x | |
| $69.5B | 0.9x | 7.5x | |
| $52.1B | 25.7x | 1434.3x | |
| $50.4B | 2.8x | 7.3x | |
| $49.0B | 3.3x | 16.8x | |
| $45.7B | 1.2x | 8.8x | |
| $43.3B | 1.6x | 7.6x | |
| $37.5B | 1.4x | 8.2x | |
| $36.6B | 0.9x | 7.9x | |
| $36.3B | 2.9x | 11.2x | |
| $34.8B | 7.3x | 19.8x | |
| $32.8B | 2.1x | 11.5x | |
| $32.6B | 1.0x | 8.9x | |
| $30.8B | 2.0x | 11.7x | |
| $30.7B | 0.9x | 8.2x | |
| $30.4B | 0.8x | 6.5x | |
| $28.8B | 2.6x | 13.4x | |
| $26.9B | 6.7x | 37.4x | |
| $26.2B | 2.2x | 13.1x | |
| $23.5B | 4.1x | 10.1x | |
| $21.4B | 2.3x | 10.4x | |
| $20.9B | 3.6x | 10.6x | |
| $19.2B | 0.5x | 2.3x | |
| $19.1B | 4.3x | 16.1x | |
| $18.9B | 1.9x | 8.6x | |
| $17.6B | 6.8x | 23.3x | |
| $17.3B | 2.9x | 13.8x | |
| $17.2B | 2.8x | 7.2x | |
| $17.1B | 1.4x | 9.7x | |
| $16.7B | 2.3x | 14.6x | |
| $16.7B | 3.2x | 11.4x | |
| $16.6B | 1.0x | 13.8x | |
| $13.8B | 1.5x | 7.8x | |
| $13.5B | 1.1x | 7.1x | |
| $13.3B | 0.8x | 5.5x | |
| $13.3B | 0.9x | 5.7x | |
| $13.0B | 2.9x | 8.6x | |
| $12.3B | 2.4x | 11.8x | |
| $11.2B | 5.0x | 11.7x | |
| $11.0B | 3.6x | 9.8x | |
| $10.4B | 1.5x | 6.0x | |
| $10.0B | 1.3x | 6.2x | |
| $9.6B | 0.5x | 5.6x | |
| $9.4B | 1.6x | 13.5x | |
| $9.2B | 2.2x | 10.3x | |
| $8.8B | 0.8x | 5.0x | |
| $8.2B | 0.6x | 3.1x | |
| $7.1B | 7.5x | 27.6x | |
| $6.7B | 2.4x | 380.9x | |
| $6.5B | 1.5x | 10.1x | |
| $6.3B | 2.9x | 8.6x | |
| $5.8B | 1.1x | 9.6x | |
| $5.7B | 1.0x | 4.8x | |
| $5.6B | 2.8x | 11.1x | |
| $5.4B | 0.7x | 7.7x | |
| $5.4B | 0.6x | 6.9x | |
| $5.4B | 6.6x | 22.8x | |
| $5.4B | 1.0x | 6.3x | |
| $5.2B | 12.2x | 38.6x | |
| $4.7B | 0.7x | 5.5x | |
| $4.7B | 1.8x | 13.8x | |
| $4.5B | 0.4x | 13.1x | |
| $4.2B | n/a | n/a | |
| $3.8B | 1.1x | 5.7x | |
| $3.7B | 0.9x | 16.0x | |
| $3.7B | 1.7x | 8.2x | |
| $3.7B | n/a | n/a | |
| $3.4B | 12.4x | 53.8x | |
| $3.2B | 5.2x | 29.6x | |
| $2.9B | 0.9x | -127.1x | |
| $2.6B | 0.6x | 3.7x | |
| $2.4B | 0.8x | 6.4x | |
| $2.4B | n/a | n/a | |
| $2.2B | 2.9x | 11.1x | |
| $2.1B | 2.2x | 11.3x | |
| $2.1B | 0.7x | 6.2x | |
| $1.8B | 0.2x | 5.2x | |
| $1.8B | 7.0x | 21.6x | |
| $1.7B | 1.5x | 11.4x | |
| $1.6B | 2.3x | 12.1x | |
| $1.6B | 1.5x | 8.8x | |
| $1.5B | 2.1x | 8.9x | |
| $1.4B | n/a | n/a | |
| $1.4B | 2.6x | n/a | |
| $1.2B | 1.2x | 11.9x | |
| $1.2B | 0.7x | 28.7x | |
| $1.0B | 0.7x | 7.2x | |
| $1.0B | 2.4x | 34.7x | |
| $756M | n/a | n/a | |
| $728M | n/a | n/a | |
| $647M | 0.2x | 37.3x | |
| $634M | 1.3x | 6.5x | |
| $614M | 0.5x | 3.7x | |
| $611M | 1.0x | 7.3x | |
| $576M | n/a | n/a | |
| $543M | 0.4x | 5.8x | |
| $532M | 1.4x | 10.1x | |
| $471M | 0.8x | 5.4x | |
| $465M | 5.7x | -14.2x | |
| $463M | 8.9x | 29.4x | |
| $445M | 1.8x | 11.4x | |
| $433M | 0.8x | 2.8x | |
| $433M | 0.6x | 5.7x | |
| $430M | 0.8x | 5.7x | |
| $351M | 0.2x | 3.3x | |
| $349M | 1.5x | 8.4x | |
| $331M | n/a | n/a | |
| $301M | 7.6x | -7.3x | |
| $292M | 0.5x | 7.3x | |
| $291M | n/a | n/a | |
| $263M | n/a | n/a | |
| $251M | n/a | n/a | |
| $211M | n/a | n/a | |
| $203M | n/a | n/a | |
| $198M | 11.3x | -6.7x | |
| $178M | 0.4x | 4.3x | |
| $169M | 146.0x | -535.0x | |
| $153M | 0.6x | 3.8x | |
| $137M | 1.2x | 6.3x | |
| $129M | n/a | n/a | |
| $120M | 5.7x | -5.9x | |
| $117M | 5.6x | 16.9x | |
| $110M | n/a | n/a | |
| $97.6M | n/a | n/a | |
| $90.4M | n/a | n/a | |
| $79.6M | 38.0x | -2.2x | |
| $78.0M | 372.7x | -12.6x | |
| $77.4M | 0.8x | 4.2x | |
| $75.9M | 0.6x | 8.8x | |
| $75.7M | n/a | n/a | |
| $64.2M | n/a | n/a | |
| $48.0M | 0.5x | 4.5x | |
| $46.6M | n/a | n/a | |
| $46.4M | 12.8x | -7.0x | |
| $44.8M | 0.8x | 18.4x | |
| $44.1M | 0.5x | 10.7x | |
| $43.1M | 2.5x | 15.1x | |
| $37.1M | 1.7x | 30.1x | |
| $35.3M | 0.5x | 40.4x | |
| $34.8M | n/a | n/a | |
| $28.5M | 2.1x | 36.1x | |
| $26.8M | n/a | n/a | |
| $25.0M | n/a | n/a | |
| $21.5M | 2.0x | -9.9x | |
| $20.7M | n/a | n/a | |
| $19.8M | n/a | n/a | |
| $17.9M | n/a | n/a | |
| $17.1M | n/a | n/a | |
| $16.7M | n/a | n/a | |
| $16.5M | n/a | n/a | |
| $16.4M | n/a | n/a | |
| $15.0M | 1.5x | -4.9x | |
| $12.0M | n/a | n/a | |
| $11.3M | n/a | n/a | |
| $10.6M | 1.7x | 315.1x | |
| $8.5M | n/a | n/a | |
| $7.0M | 46.4x | -1.9x | |
| $6.9M | 133.3x | -9.0x | |
| $6.2M | n/a | n/a | |
| $5.6M | n/a | n/a | |
| $5.5M | n/a | n/a | |
| $5.2M | n/a | n/a | |
| $4.4M | n/a | n/a | |
| $4.2M | n/a | n/a | |
| $3.8M | n/a | n/a | |
| $3.6M | n/a | n/a | |
| $2.8M | n/a | n/a | |
| $2.7M | 7.7x | -0.2x | |
| $2.6M | n/a | n/a | |
| $2.0M | n/a | n/a | |
| $1.7M | n/a | n/a | |
| $1.5M | n/a | n/a | |
| $1.1M | n/a | n/a | |
| $1.0M | n/a | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Chemicals